We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

42 hedge funds and large institutions have $37.8M invested in Bio-Path Holdings Inc in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,550% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 2

282% more funds holding

Funds holding: 1142 (+31)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

35% more capital invested

Capital invested by funds: $27.9M → $37.8M (+$9.86M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
42
Holders Change
+31
Holders Change %
+281.82%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
33
Increased
5
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$13.3M -$6.99M -638 -37%
BFA
2
BlackRock Fund Advisors
California
$5.51M +$4.95M +452 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.5M +$4.04M +369 New
BIT
4
BlackRock Institutional Trust
California
$2.26M +$2.03M +185 New
State Street
5
State Street
Massachusetts
$2.11M +$1.9M +173 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.48M +$1.26M +115 +1,917%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$968K +$811K +74 +1,480%
TCIM
8
TIAA CREF Investment Management
New York
$936K +$844K +77 New
Northern Trust
9
Northern Trust
Illinois
$764K +$690K +63 New
BIM
10
BlackRock Investment Management
Delaware
$633K +$570K +52 New
Millennium Management
11
Millennium Management
New York
$570K +$515K +47 New
Goldman Sachs
12
Goldman Sachs
New York
$522K +$274K +25 +139%
Morgan Stanley
13
Morgan Stanley
New York
$447K +$384K +35 +1,750%
California State Teachers Retirement System (CalSTRS)
14
California State Teachers Retirement System (CalSTRS)
California
$409K +$373K +34 New
Charles Schwab
15
Charles Schwab
California
$329K +$296K +27 New
TA
16
Teachers Advisors
New York
$312K +$285K +26 New
MLICM
17
Metropolitan Life Insurance Company (MetLife)
New York
$267K +$241K +22 New
VOYA Investment Management
18
VOYA Investment Management
Georgia
$209K +$186K +17 New
HighTower Advisors
19
HighTower Advisors
Illinois
$195K +$274K +25 +10%
SG Americas Securities
20
SG Americas Securities
New York
$173K +$153K +14 New
NFA
21
Nationwide Fund Advisors
Ohio
$168K +$153K +14 New
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$161K +$142K +13 New
Creative Planning
23
Creative Planning
Kansas
$153K -$197K -18 -58%
Jane Street
24
Jane Street
New York
$148K +$131K +12 New
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$148K +$131K +12 New

BPTH Hedge Fund Activity: Q2 2014 in Review

42 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2014, worth a combined $37.8M — up 35% from $27.9M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BPTH positions and 2 closed out — a net gain of 31 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.95M. The largest seller was Sabby Management, exiting entirely with an estimated $8.78M sold.

  • 42 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2014, up from 11 in Q1 2014.
  • Funds reported $37.8M of Bio-Path Holdings Inc stock for Q2 2014, up 35% quarter-over-quarter.
  • 33 funds opened new Bio-Path Holdings Inc positions in Q2 2014 and 2 closed out, a net change of +31 holders.
  • The largest Bio-Path Holdings Inc buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.95M added.
  • The largest Bio-Path Holdings Inc seller in Q2 2014 was Sabby Management, an estimated $8.78M sold.

Based on aggregated 13F filings for Q2 2014.